Source externe
ScienceDaily – Health & Medicine
Cancer uses antioxidants to disarm the immune system, scientists discover
Scientists have discovered that tumors release natural antioxidants to shut down the immune cells responsible for destroying cancer, exploiting a surprising weakness in the body's defenses. Blocking this mechanism in mice restored immune activity and improved immunotherapy…
le 10 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Blood RNA signal may reveal ovarian cancer precursors before invasive disease develops
Hoag researchers have discovered a molecular warning signal in the blood that identifies serous tubal intraepithelial carcinoma (STIC), an early, precancerous stage of high-grade serous ovarian cancer (HGSOC). This advance is particularly significant because ovarian cancer is…
le 10 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Slow hands, quiet nights? Tai chi and a matched exercise class nudged sleep about equally in older men after cancer
Sleep disturbances affect up to 60% of people after primary cancer treatment, and they are often waved away as the price of treatment, or of age. For older men in particular, science has had little to offer. Most research on behavioral treatments for insomnia has studied women…
le 10 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Cancer patients' voices could help improve care across Australia
Australians living with cancer are increasingly being asked a simple but powerful question: How are you? A study led by Flinders University and Flinders Medical Center describes how clinicians routinely listening to cancer patients about their symptoms, well-being and quality of…
le 9 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
New drug combination improves survival in patients with muscle-invasive bladder cancer
A new treatment approach could help people with an aggressive form of bladder cancer live longer and reduce the chances of their cancer returning or progressing, particularly those who cannot receive standard chemotherapy, according to findings from a large international…
le 9 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer
Researchers have identified a promising new target in the treatment of pancreatic cancer. A new study in The American Journal of Pathology demonstrates that blocking complement factor B (CFB), a pivotal enzyme in the alternative complement pathway, halts cancer growth and alters…
le 9 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Q&A: Researcher investigates pharmacological approaches to breast cancer prevention
In a new thesis, Mattias Hammarström studied whether lower doses of tamoxifen and also its active metabolite endoxifen for direct administration, as a preventive medication could reduce side effects while still affecting breast tissue in healthy women. The findings suggest that…
le 9 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Heterogeneity in breast cancer linked to risk of metastasis and treatment response
Differences within breast tumors and between patients are associated with the risk of metastasis and response to endocrine therapy, according to a new doctoral thesis from Karolinska Institutet. The findings also highlight the importance of long-term follow-up in capturing the…
le 9 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Scientists turn protein-making errors in cancer cells into a targeted kill switch
Like every other cell in the human body, cancer cells also produce their own share of proteins for survival. During this production process, cells often encounter a glitch called ribosomal frameshifting. This exceptionally rare event occurs roughly once in every 100,000…
le 9 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Childhood cancers may spread by 'shape-shifting' rather than mutating
Researchers at the University of East Anglia (UK) have proposed an explanation for why some childhood tumors spread aggressively around the body despite having relatively few genetic faults. For years, experts believed cancers become more dangerous by accumulating genetic…
le 9 nov. 2026· OncologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
A simple supplement may help clear brain fog after cancer
A surprising new study from UCLA suggests that a naturally occurring molecule could help breast cancer survivors overcome the frustrating brain fog and exhaustion that can linger long after treatment ends. Researchers found that women taking an oxaloacetate supplement for eight…
le 9 nov. 2026· OncologieLire chez la source
Source externe
Inserm – Actualités & Recherche
Raphaël Ceccaldi : double cursus, double culture
Et s’il était possible de détruire certaines cellules cancéreuses quand elles se multiplient ? C’est la voie prometteuse vers des traitements novateurs qu’a ouverte Raphaël Ceccaldi, chercheur au parcours atypique. Un article à retrouver dans le magazine de l’Inserm n°70…
le 9 nov. 2026· OncologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
Scientists wipe out deadly brain tumors in every mouse tested with new cancer therapy
Scientists at UC San Francisco have developed a powerful new cancer therapy that remains inactive until it reaches the brain, where it switches on to attack deadly tumors. The engineered immune cells, called B-SYNC CAR-T cells, completely eliminated diffuse midline glioma (DMG)…
le 8 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Aspirin does not prevent recurrence after treatment for colorectal cancer liver metastases
Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world.
le 8 nov. 2026· OncologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
MIT scientists turn immune cells into cancer killers inside the body
MIT scientists have developed nanoparticles that reprogram immune cells directly inside the body to attack cancer and harmful immune cells, eliminating tumors and reversing liver damage in mouse experiments. The breakthrough could make powerful immune therapies dramatically…
le 8 nov. 2026· OncologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
Low testosterone linked to 18% higher risk of dying from cancer
A major international study tracking more than 26,000 men found that very low testosterone levels were associated with an 18% higher risk of dying from cancer later in life. Surprisingly, testosterone itself showed no clear link to prostate cancer, although two other sex…
le 8 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
New research identifies biological differences in pancreatic cancer
New research from the University of Cincinnati Cancer Center found biological differences in pancreatic cancer tumors and immune environments, opening the possibility for more personalized treatments for different populations.
le 6 nov. 2026· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
DNA 'switch' uncovers new brake on breast cancer growth
Adelaide University researchers have found a DNA "switch" that helps the body stop the growth of the most common form of breast cancer, providing new insights that could help with future treatments. Up to 80% of breast cancer cases are classified as estrogen receptor-positive…
le 6 nov. 2026· OncologieLire chez la source
